Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
Oncol Rep
; 36(4): 2193-9, 2016 Oct.
Article
in En
| MEDLINE
| ID: mdl-27509921
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Neuropeptide Y
/
Carcinoma, Hepatocellular
/
Proto-Oncogene Proteins c-akt
/
NIMA-Related Kinases
/
Liver Neoplasms
Limits:
Humans
Language:
En
Journal:
Oncol Rep
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article